Maro Ohanian
Impact in
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 98
- Acute Myeloid Leukemia Research 77
- Chronic Myeloid Leukemia Treatments 39
- Genetics 50
- Chronic Lymphocytic Leukemia Research 25
- Myeloproliferative Neoplasms: Diagnosis and Treatment 21
- Co-authors
- Hagop M. Kantarjian (84 shared papers)Farhad Ravandi (75 shared papers)Jörge E. Cortes (59 shared papers)Elias Jabbour (66 shared papers)Tapan M. Kadia (65 shared papers)Gautam Borthakur (63 shared papers)Guillermo Garcia‐Manero (71 shared papers)Naval Daver (51 shared papers)
- Journals
- Blood (58 papers)Journal of Clinical Oncology (16 papers)American Journal of Hematology (10 papers)Leukemia Research (3 papers)Blood Cancer Journal (2 papers)
- Partner nations
- United StatesGeorgiaArmenia
In The Last Decade
Maro Ohanian
114 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 76
- Hematology 1.2k
- Genetics 446
- Public Health, Environmental and Occupational Health 293
- Oncology 268
- Immunology 204
Countries citing papers authored by Maro Ohanian
This map shows the geographic impact of Maro Ohanian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maro Ohanian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maro Ohanian more than expected).
Fields of papers citing papers by Maro Ohanian
This network shows the impact of papers produced by Maro Ohanian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maro Ohanian. The network helps show where Maro Ohanian may publish in the future.
Co-authors
The 25 scholars most cited alongside Maro Ohanian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 123 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 104 | |
| 2 | 2016 | 99 | |
| 3 | 2018 | 95 | |
| 4 | 2019 | 88 | |
| 5 | 2022 | 65 | |
| 6 | 2017 | 58 | |
| 7 | 2021 | 53 | |
| 8 | 2011 | 49 | |
| 9 | 2018 | 49 | |
| 10 | 2016 | 46 | |
| 11 | 2012 | 42 | |
| 12 | 2014 | 42 | |
| 13 | 2013 | 38 | |
| 14 | 2018 | 38 | |
| 15 | 2017 | 37 | |
| 16 | 2017 | 37 | |
| 17 | 2012 | 37 | |
| 18 | 2018 | 37 | |
| 19 | 2013 | 35 | |
| 20 | 2016 | 33 |
About Maro Ohanian
Maro Ohanian is a scholar working on Hematology, Genetics, Molecular Biology, Public Health, Environmental and Occupational Health and Oncology, having authored 123 papers that have together received 1.8k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (77 papers), Chronic Myeloid Leukemia Treatments (39 papers), Chronic Lymphocytic Leukemia Research (25 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (21 papers), Acute Lymphoblastic Leukemia research (19 papers), Histone Deacetylase Inhibitors Research (19 papers), Protein Degradation and Inhibitors (11 papers) and Lymphoma Diagnosis and Treatment (8 papers). The work is most often cited by research in Hematology (1.2k citations), Genetics (446 citations), Public Health, Environmental and Occupational Health (293 citations), Oncology (268 citations) and Immunology (204 citations). Maro Ohanian has collaborated with scholars based in United States, Georgia and Armenia. Frequent co-authors include Hagop M. Kantarjian, Farhad Ravandi, Jörge E. Cortes, Elias Jabbour, Tapan M. Kadia, Gautam Borthakur, Guillermo Garcia‐Manero, Naval Daver, Marina Konopleva and Naveen Pemmaraju. Their work appears in journals such as Blood, Journal of Clinical Oncology, American Journal of Hematology, Leukemia Research and Blood Cancer Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.